Fortress Biotech
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $14,629 | $14,896 | $13,030 | $19,946 |
Gross Profit | 9,344 | 8,355 | 6,214 | 13,554 |
EBITDA | -22,095 | -26,142 | -35,375 | -24,836 |
EBIT | -23,468 | -27,333 | -37,094 | -26,545 |
Net Income | -12,867 | -10,948 | -17,731 | -9,279 |
Net Change In Cash | 14,629 | 14,896 | 13,030 | 19,946 |
Free Cash Flow | 47,225 | -21,838 | -25,387 | -34,998 |
Cash | 58,853 | 76,201 | 85,837 | 80,927 |
Basic Shares | 19,697 | 18,316 | 17,151 | 10,750 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $84,513 | $75,743 | $68,791 | $45,599 |
Gross Profit | 57,853 | 44,968 | 36,707 | 31,005 |
EBITDA | -133,643 | -190,469 | -142,254 | -87,820 |
EBIT | -141,718 | -199,822 | -149,045 | -93,145 |
Net Income | -60,637 | -213,913 | -164,826 | -102,985 |
Net Change In Cash | 84,513 | 75,743 | 68,791 | 45,599 |
Cost of Revenue | 72,968 | 81,564 | ||
Free Cash Flow | -136,323 | -182,456 | -132,886 | -90,846 |
Cash | 80,927 | 178,266 | 305,744 | 233,351 |
Basic Shares | 8,110 | 5,924 | 5,446 | 4,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.73 |
2024-03-31 | -$1.03 |
2023-12-31 | -$1.28 |
2023-09-30 | -$0.94 |
